Literature DB >> 18087048

Structure of the measles virus H glycoprotein sheds light on an efficient vaccine.

Rob W H Ruigrok1, Denis Gerlier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18087048      PMCID: PMC2409202          DOI: 10.1073/pnas.0709995105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

1.  Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?

Authors:  Sabine Santibanez; Stefan Niewiesk; Alla Heider; Jürgen Schneider-Schaulies; Guy A M Berbers; Albert Zimmermann; Anne Halenius; Anne Wolbert; Ingrid Deitemeier; Annedore Tischer; Hartmut Hengel
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

2.  NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family.

Authors:  Erhu Cao; Udupi A Ramagopal; Alexander Fedorov; Elena Fedorov; Qingrong Yan; Jeffrey W Lary; James L Cole; Stanley G Nathenson; Steven C Almo
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

3.  Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.

Authors:  Kah-Whye Peng; Kathleen A Donovan; Urs Schneider; Roberto Cattaneo; John A Lust; Stephen J Russell
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

4.  A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism.

Authors:  Makoto Takeda; Maino Tahara; Takao Hashiguchi; Takeshi A Sato; Fumiaki Jinnouchi; Shoko Ueki; Shinji Ohno; Yusuke Yanagi
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

5.  Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response.

Authors:  O T Ertl; D C Wenz; F B Bouche; G A M Berbers; C P Muller
Journal:  Arch Virol       Date:  2003-11       Impact factor: 2.574

6.  Crystal structure of measles virus hemagglutinin provides insight into effective vaccines.

Authors:  Takao Hashiguchi; Mizuho Kajikawa; Nobuo Maita; Makoto Takeda; Kimiko Kuroki; Kaori Sasaki; Daisuke Kohda; Yusuke Yanagi; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

7.  Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells.

Authors:  Fumio Seki; Nobuyuki Ono; Ryoji Yamaguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles.

Authors:  Fernando P Polack; Scott J Hoffman; Gonzalo Crujeiras; Diane E Griffin
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

9.  Wild-type Rinderpest virus uses SLAM (CD150) as its receptor.

Authors:  Michael D Baron
Journal:  J Gen Virol       Date:  2005-06       Impact factor: 3.891

10.  Structure of an unliganded simian immunodeficiency virus gp120 core.

Authors:  Bing Chen; Erik M Vogan; Haiyun Gong; John J Skehel; Don C Wiley; Stephen C Harrison
Journal:  Nature       Date:  2005-02-24       Impact factor: 49.962

View more
  3 in total

1.  Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM.

Authors:  Takao Hashiguchi; Toyoyuki Ose; Marie Kubota; Nobuo Maita; Jun Kamishikiryo; Katsumi Maenaka; Yusuke Yanagi
Journal:  Nat Struct Mol Biol       Date:  2011-01-09       Impact factor: 15.369

2.  Measles virus hemagglutinin: structural insights into cell entry and measles vaccine.

Authors:  Takao Hashiguchi; Katsumi Maenaka; Yusuke Yanagi
Journal:  Front Microbiol       Date:  2011-12-16       Impact factor: 5.640

Review 3.  The Use of Synthetic Carriers in Malaria Vaccine Design.

Authors:  Liam Powles; Sue D Xiang; Cordelia Selomulya; Magdalena Plebanski
Journal:  Vaccines (Basel)       Date:  2015-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.